Related Experiment Videos
Tay-Sachs disease screening and diagnosis: evolving technologies
1De Belle Laboratory for Biochemical Genetics, McGill University-Montreal Children's Hospital Research Institute, Quebec, Canada.
DNA and Cell Biology
|October 1, 1993
Summary
Tay-Sachs disease (TSD) is a fatal neurodegenerative disorder diagnosed by hexosaminidase A deficiency. Community screening programs, utilizing enzymatic and DNA-based methods, aim to reduce TSD incidence.
Area of Science:
- Neurogenetics
- Biochemistry
- Medical Diagnostics
Background:
- Tay-Sachs disease (TSD) is an inherited neurodegenerative disorder caused by hexosaminidase A deficiency.
- Early diagnosis and carrier identification are crucial for managing genetic conditions.
- TSD was the first genetic disease targeted for community-based carrier screening.
Purpose of the Study:
- To review the clinical, biochemical, and molecular aspects of Tay-Sachs disease.
- To examine the evolution of laboratory technologies for TSD screening.
- To discuss the impact of DNA-based methods and the social context of genetic screening.
Main Methods:
- Review of clinical, biochemical, and molecular features of TSD.
- Analysis of enzymatic and DNA-based diagnostic assays.
- Examination of community genetic screening program methodologies.
Main Results:
- Enzymatic deficiency of hexosaminidase A is the basis for TSD diagnosis and carrier identification.
- Advancements in laboratory technology have improved screening accuracy.
- DNA-based technology offers enhanced capabilities for identifying carriers of TSD-associated mutations.
Conclusions:
- Enzymatic and DNA-based tests facilitate TSD diagnosis and carrier screening.
- Community screening programs have evolved significantly, with DNA technology playing a key role.
- Understanding the social context is vital for effective genetic screening initiatives.